Koss Corporation Releases Third Quarter Results
May 09, 2024 17:15 ET
|
Koss Corporation
MILWAUKEE, Wis., May 09, 2024 (GLOBE NEWSWIRE) -- Koss Corporation (NASDAQ: KOSS) (the “Company”), a U.S. based high-fidelity headphone company, has reported its results for the third quarter ended...
Legacy Housing Corporation Reports First Quarter 2024 Financial Results
May 09, 2024 17:00 ET
|
Legacy Housing Corporation
Legacy Housing Corporation Reports First Quarter 2024 Financial Results
Quipt Home Medical Corp. Announces Filing of Final Base Shelf Prospectus
May 09, 2024 17:00 ET
|
Quipt Home Medical Corp.
CINCINNATI, Ohio, May 09, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory...
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
May 09, 2024 17:00 ET
|
Tarsus Pharmaceuticals, Inc
IRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize...
BankFinancial Corporation Reports Financial Results for the First Quarter 2024
May 09, 2024 16:58 ET
|
BankFinancial Corporation
BURR RIDGE, Ill., May 09, 2024 (GLOBE NEWSWIRE) -- BankFinancial Corporation (Nasdaq – BFIN) (“BankFinancial”) filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024, and a...
vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update
May 09, 2024 16:51 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a clinical stage biopharmaceutical company focused on the development of an adjunctive therapy to insulin for...
23andMe to Report Q4 and Full Year FY2024 Financial Results
May 09, 2024 16:50 ET
|
23andMe, Inc.
SOUTH SAN FRANCISCO, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a mission to help people access,...
Innospec Reports First Quarter 2024 Financial Results
May 09, 2024 16:45 ET
|
Innospec Inc.
Strong contribution from Performance Chemicals drives operating income growth of 23 percent $80.6 million cash generated from operations; Net cash improves to $270.1 million Dividend...
Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
May 09, 2024 16:42 ET
|
Arvinas Inc.
NEW HAVEN, Conn., May 09, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) today announced that two posters, including updated clinical trial data, for vepdegestrant will be presented at the...
Mawson Infrastructure Group Announces Hiring of Head of Corporate Strategy and Head of Corporate Development
May 09, 2024 16:35 ET
|
Mawson Infrastructure Group Inc.
Mawson Infrastructure Group Announces Hiring of Head of Corporate Strategy and Head of Corporate Development